NEI Grant Boosts Fight Against Retinal Disease
A $10-million grant from the National Eye Institute will help the School of Medicine develop new treatments for retinal disease, a leading cause of blindness. The five-year grant will fund the work of researchers in the departments of pharmacology, ophthalmology and biomedical engineering who are working in collaboration with the Retinal Therapeutics Study Group.
"This research is critical to availing patients of new, more effective treatments, particularly for diseases like age-related macular degeneration, for which there is currently no cure," says principal investigator Krzysztof Palczewski, PhD, the John H. Hord Professor and chair of the Department of Pharmacology.
The interdisciplinary team will screen existing drugs for potential effectiveness in treating retinal diseases.